慢性血栓栓塞性肺病的当前手术管理
Hayley Barnes1,2, Daniel Niewodowski1,3, Atsuo Doi4
1Department of Respiratory Medicine, Alfred Hospital, Melbourne, Victoria, Australia.
Internal medicine journal
|August 1, 2024
概括
肺内关节切除术 (PEA) 为慢性血栓栓塞性肺病与肺高血压 (CTEPH) 提供了很好的结果,但也存在风险. 这篇评论详细介绍了PEA的细节.
科学领域:
- 心脏病学 心脏病学
- 肺部医学 肺部医学
- 血管外科 血管外科
背景情况:
- 慢性血栓栓塞性肺病 (CTEPD) 有或没有肺高血压 (PH) 可能由静脉血栓塞性疾病引起.
- 未经治疗的带有PH的CTEPD (CTEPH) 会导致严重的发病率和死亡率.
- 对于CTEPD/CTEPH的治疗选择包括肺内关节切除术 (PEA),气球肺血管整形术,药物治疗或组合方法.
研究的目的:
- 审查澳大利亚PEA在CTEPH管理中的历史和当前作用.
- 报告来自澳大利亚主要的CTEPH专家中心的结果.
- 提供关于PEA利用的最新指导,并讨论CTEPH诊断和管理的未来挑战.
主要方法:
- 在澳大利亚CTEPH中心对PEA结果的回顾性分析.
- 对CTEPH的现有文献和治疗指南的审查.
- 讨论患者选择标准,外科考虑和多学科管理.
主要成果:
- 在精选的CTEPH患者中,PEA可以实现出色的结果和疾病解决.
- 治疗选择受疾病的位置,PH严重程度和患者因素的影响.
- PEA是一种复杂的手术,有可能导致严重的术后并发症.
结论:
- 在澳大利亚,PEA仍然是适合CTEPH患者的基石治疗.
- 优化患者选择和外科专业知识对于成功的PEA结果至关重要.
- 需要继续进行研究和合作,以应对CTEPH诊断和管理方面的挑战.
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Pneumothorax-II
131
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
131
Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.7K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.7K
Pulmonary Tuberculosis V
176
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
176
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
165
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
165
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K


